HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Increased cortical surface area and gyrification following long-term survival from early monocular enucleation.

AbstractPURPOSE:
Retinoblastoma is typically diagnosed before 5 years of age and is often treated by enucleation (surgical removal) of the cancerous eye. Here, we sought to characterize morphological changes of the cortex following long-term survival from early monocular enucleation.
METHODS:
Nine adults with early right-eye enucleation (≤48 months of age) due to retinoblastoma were compared to 18 binocularly intact controls. Surface area, cortical thickness, and gyrification estimates were obtained from T1 weighted images and group differences were examined.
RESULTS:
Early monocular enucleation was associated with increased surface area and/or gyrification in visual (i.e., V1, inferior temporal), auditory (i.e., supramarginal), and multisensory (i.e., superior temporal, inferior parietal, superior parietal) cortices compared with controls. Visual cortex increases were restricted to the right hemisphere contralateral to the remaining eye, consistent with previous subcortical data showing asymmetrical lateral geniculate nucleus volume following early monocular enucleation.
CONCLUSIONS:
Altered morphological development of visual, auditory, and multisensory regions occurs subsequent to long-time survival from early eye loss.
AuthorsKrista R Kelly, Kevin D DeSimone, Brenda L Gallie, Jennifer K E Steeves
JournalNeuroImage. Clinical (Neuroimage Clin) Vol. 7 Pg. 297-305 ( 2015) ISSN: 2213-1582 [Electronic] Netherlands
PMID25610793 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Topics
  • Adolescent
  • Adult
  • Age of Onset
  • Cerebral Cortex (growth & development, physiopathology)
  • Child, Preschool
  • Eye Enucleation
  • Female
  • Humans
  • Image Processing, Computer-Assisted
  • Magnetic Resonance Imaging
  • Male
  • Middle Aged
  • Retinal Neoplasms (surgery)
  • Retinoblastoma (surgery)
  • Survivors
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: